The QualityStocks Daily Wednesday, October 30th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (ZPAS) +60.83%

PennyPickAlerts (GPIW) +55.50%

StreetInsider (BGFV) +44.81%

The QualityStocks Daily Stock List

Columbia Care, Inc. (CCHWF)

InvestorX, Pot Stock News, New Cannabis Ventures, The Cannabis Reporter, Market Screener, InvestorsHub, TradingView, Technical420, Seeking Alpha, MarketWatch, TipRanks, Investing.com, Wallet Investor, Stockwatch, Dividend.com, BioSpace, GuruFocus, and Stockhouse reported previously on Columbia Care, Inc. (CCHWF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Columbia Care, Inc. operates in the medical cannabis industry in the United States and the European Union (EU). The Company provides a portfolio of high-quality cannabis-based health and wellness solutions. Its goal is to lead the industry through taking advantage of data and research to fuel innovation and improve access to cannabis and plant-based solutions. Formed in 2012, Columbia Care has its corporate headquarters in New York, New York. The Company’s shares trade on the OTC Markets Group’s OTCQX.

Columbia Care has established partnerships with some of the world’s foremost research institutions, universities, and medical schools to further medical cannabis research. This allows for timely and relevant data collection and analysis, to propel future innovation.

Columbia Care has locations all across the U.S. It has locations in Arizona, California, Delaware, Florida, Illinois, Massachusetts, New York, Pennsylvania, Puerto Rico, and Maryland.

The Company’s patient-centric emphasis includes one-on-one consultations and follow-ups with pharmacists and experts. Columbia Care offer brands and products that meet high standards of potency, purity, as well as predictability.

The Company’s proprietary, patent-pending medical brands are TheraCeed™, ClaraCeed™ and EleCeed™. These are pharmaceutical-quality and come in an array of formats. These formats include hard-pressed tablets, suppositories, vapes, as well as lotions.

Columbia Care is an experienced multi-state operator. Some of its important achievements include six-plus years of strong organic growth, 1 million patient sales transactions, 63 facilities in operation or development, and 39 licenses in 15 markets.

In addition to its medical cannabis products, Columbia Care also offers an assortment of health and wellness brands and products. These include its own hemp CBD (cannabidiol) brands, which are full spectrum, independent 3rd party tested, organic, GMO-free, and produced in cGMP-compliant facilities. The Company’s flagship hemp CBD brand, Columbia Care Platinum Label, aims to set the standard in potency and purity.

Columbia Care, Inc. (CCHWF), closed Wednesday's trading session at $3.14, up 0.443487%, on 7,960 volume with 14 trades. The average volume for the last 3 months is 8,513 and the stock's 52-week low/high is $2.88000011/$7.19910001.

chart

Ecoark Holdings, Inc. (ZEST)

NetworkNewsWire, TipRanks, TeleTrader, Last10k, Whale Wisdom, Wallet Investor, Market Screener, Morningstar, GlobeNewswire, Simply Wall Street, Stockhouse, Stockopedia, and TradingView reported beforehand on Ecoark Holdings, Inc. (ZEST), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Ecoark Holdings, Inc. is an AgTech company modernizing the post-harvest fresh food supply chain for a broad range of organizations. These include growers, suppliers, distributors, as well as retailers. The Company’s wholly-owned subsidiary, is Zest Labs™. Established in 2011, Ecoark Holdings has its head office in San Jose, California. The Company’s shares trade on the OTC Markets Group’s OTCQX.

Zest Labs’™ headquarters is located in the heart of the Silicon Valley, close to many of the world’s most famous agricultural regions. This provides it with fast access to the innovative insights and perspectives of growers, producers, as well as processors.

Zest Labs offers the Zest Fresh™ solution. This is a pioneering approach to the quality management of fresh food. It is purposely designed to help considerably lessen the $161 billion amount of food loss the Unites States experiences each year. By way of item-level monitoring and real-time predictive analytics, Zest Fresh enables customers to improve the freshness and quality of produce and proteins, realize major cost savings, and also decrease food waste.

Ecoark Holdings’ Zest Fresh solution enables growers, packers, shippers, distributors, and retailers to proactively monitor and manage food freshness in the supply chain. This provides the ability to decrease waste by 50 percent or more and improve product margins by six percent or more.

The Company’s Zest Fresh for Produce, Zest Fresh for Protein, and Zest Delivery solutions provide the members of the fresh food supply chain with the information and actionable insights they need to optimize the fresh food supply chain operations to lessen waste. They also provide the information and actionable insights they need to provide true transparency and supply chain visibility for food safety and authenticity, and the information and actionable insights they need to promote food and environmental sustainability. They also provide the information and actionable insights to improve operational efficiency, labor and asset utilization and lessen costs, and increase brand loyalty and create competitive advantage in the marketplace.

Ecoark Holdings is expanding into Financial Services. This past June, it announced that it entered into a definitive agreement to acquire Trend Discovery Holdings, Inc., a fund management company with a successful eight-year track record for its investors. Trend’s fund manager, Mr. William B. Hoagland, CFA, was additionally named Principal Financial Officer of Ecoark. Ecoark also executed a non-binding Letter of Intent (LOI) to acquire Nepsis, Inc.™. Founded in 1995, Nepsis is a well-established asset management and financial planning company built upon its robust “Invest With Clarity™” brand.

Ecoark Holdings, Inc. (ZEST), closed Wednesday's trading session at $1.09, up 3.8095%, on 182,841 volume with 166 trades. The average volume for the last 3 months is 126,423 and the stock's 52-week low/high is $0.435699999/$1.21000003.

chart

Gulf Keystone Petroleum Limited (GUKYF)

Value Forum, Morningstar, OTC Markets, Stock Digest, Trading View, Whale Wisdom, Real Investment Advice, Wallet Investor, Investors Hangout, 4-Traders, Seeking Alpha, Market Screener, Pink Investing, Dividend Investor, Equity Clock, and Stockhouse reported beforehand on Gulf Keystone Petroleum Limited (GUKYF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Gulf Keystone Petroleum Limited is a foremost independent operator and producer in the Kurdistan Region of Iraq. It is the operator of the Shaikan oil field with current production capacity of 40,000 barrels of oil per day. The Company has a premier track record of demonstrated drilling and operating successes in the Kurdistan region of Iraq. Gulf Keystone Petroleum International Ltd. (GKPI) is a wholly-owned subsidiary of Gulf Keystone Petroleum. Gulf Keystone Petroleum has its corporate office in Hamilton, Bermuda. The Company’s shares trade on the OTC Markets Group’s OTCQX.

GKPI holds an interest in the Shaikan Block Production Sharing Contract (PSC), where it is also the operator. On August 6, 2009, Gulf Keystone announced a significant discovery with the Shaikan-1 exploration well. In August of 2012, it declared Shaikan a commercial discovery. In June 2013, the Shaikan Field Development Plan was approved.

The Shaikan block, operated by Gulf Keystone, is about 60 km to the north-west of Erbil covering an area of 283 km². The Production Sharing Contract (PSC) for the Shaikan block was awarded in November of 2007. Gulf Keystone Petroleum’s strategy is to move to the large-scale staged development of the Shaikan field.

The phased development approach to the implementation of the Shaikan Field Development Plan will enable the Company to achieve a considerable ramp up of production. An element of Gulf Keystone’s near-term strategy is to maintain production from Shaikan production facilities at 40,000 bopd, with a view to boosting to 55,000 bopd, and further beyond.

Gulf Keystone Petroleum’s success in the Kurdistan region of Iraq to date is supported by the high-caliber team it has in place, and also long standing relationships on the ground with the Ministry of Natural Resources of the Kurdistan Regional Government. Its success in the region is also supported by transparency with surrounding communities and businesses in the areas in which it operates. On October 16, 2019, Gulf Keystone Petroleum (GKP) confirmed that a gross payment of $21.5 million ($16.8 million net to GKP) was received from the Kurdistan Regional Government for Shaikan crude oil sales during July of 2019.

Gulf Keystone Petroleum Limited (GUKYF), closed Wednesday's trading session at $2.68, even for the day, on 1 volume. The average volume for the last 3 months is 476 and the stock's 52-week low/high is $2.04999995/$3.58999991.

chart

Iota Communications, Inc. (IOTC)

Zacks, Market Wire News, Wall Street Reporter, Market Screener, Street Insider, Whale Wisdom, Real Investment Advice, Investing.com, Last10k, Wallet Investor, Stockopedia, Stockhouse, TradingView, InvestorsHub, PR Newswire, Investors Hangout, and Stockwatch reported earlier on Iota Communications, Inc. (IOTC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Iota Communications, Inc. is a wireless network carrier and software service company based in New Hope, Pennsylvania. It provides Internet of Things (IoT) solutions that optimize energy efficiency, sustainability, and operations for commercial facilities. The Company provides data-driven insights for sustainability enabled by its network connectivity, advanced analytics platform, and software-as-a-service (SaaS) solutions for commercial and industrial markets throughout the U.S. Iota Communications lists on the OTC Markets’ OTCQB.

Additionally, Iota Communications offers important ancillary products and services that facilitate the adoption of its subscription-based services. This includes solar energy, LED lighting, and HVAC implementation services. In essence, the Company employs technology and connectivity to help businesses save money and become more sustainable.

Regarding Collecting, easy-to-install wireless sensors, meters and devices unlock valuable data from an organization’s existing infrastructure (Mechanical, Electrical and Environmental). This provides visibility into a company’s facility operations.

Concerning Analysis, the Company’s BrightAI platform gives an organization the insights and alerts to increase operational visibility and proactively manage their facility. Consequently, a company can identify opportunities, improve performance, as well as share insights across teams and organizations. Pertaining to Optimization, Iota’s platform (combining data and analytics) provides a continuous feedback loop. This optimizes energy efficiency, improves the performance of a firm’s operations, and drives substantial savings for a facility.

Concerning Connecting, using its own 800 MHz FCC-licensed spectrum and multi-access gateways, Iota’s network is purpose built for the IoT. It offers superior building penetration, more reliable coverage, and also secure data transmission.

Iota Communications closed its Spectrum Partners Program and at the same launched its Iota Spectrum Partners, LP, an Arizona Limited Partnership (Iota Partners), to consolidate exclusive FCC Radio Spectrum Authorizations now owned and leased by Iota Networks, LLC (Iota Networks), a wholly-owned subsidiary of Iota Communications.

In July 2019, Iota Communications submitted 637 applications for 800 MHz FCC licensed spectrum on behalf of the Company and its spectrum partners and to date (as of October 15, 2019 press release), 375 licenses have been granted in connection with those applications. The Company expects the remaining licenses to be granted over the coming months. This will move Iota considerably closer to attaining full U.S. population spectrum coverage.

This month, Iota Communications announced its financial results for the Fiscal 2020 Q1 ended August 31, 2019. Revenue for Q1 of Fiscal Year (FY) 2020 was $871,774. This represents a significant increase versus Revenue of $49,796 in Q1 of Fiscal 2019. Gross Profit rose to $47,828 from $16,819 year over year. This represents an increase of 184 percent. This increase in Revenue and Gross Profit reflect growth in Iota’s services business from the Solbright merger in September of 2018.

Iota Communications posted a Loss from Operations of $6,769,403 in the period in comparison to a loss from operations of $15,796,945 in Q4 of FY 2019. This represents a quarter over quarter decrease in losses of $9,027,542.

Iota Communications, Inc. (IOTC), closed Wednesday's trading session at $0.28, off by 9.6774%, on 78,994 volume with 17 trades. The average volume for the last 3 months is 60,524 and the stock's 52-week low/high is $0.27000001/$0.75.

chart

LandStar, Inc. (LDSRD)

Zacks, TipRanks, Street Insider, Silicon Investor, Stockwatch, Nasdaq, Stockhouse, InvestorsHub, GuruFocus, TMXmoney, Morningstar, TradingView, Seeking Alpha, Simply Wall St, and OTC Markets reported previously on LandStar, Inc. (LDSRD), and today we report on the Company, here at the QualityStocks Daily Newsletter.

LandStar, Inc. is the parent company of Data443™ Risk Mitigation, Inc., a foremost data security and privacy company. Via its wholly-owned subsidiary DATA443™ Risk Mitigation, LandStar enables secure data - across local devices, network, cloud, and databases - at rest and in-flight. The Company’s products and services are central to cyber data security, GDPR, compliance, and governance capabilities. LandStar is headquartered in Raleigh, North Carolina.

The Company’s family of products include ArcMail, a top provider of simple, secure and cost-effective email and enterprise archiving and management solutions. In addition, products include ARALOC™, a market leading secure, cloud-based platform for the management, protection and distribution of digital content to the desktop and mobile devices that protects an organization’s confidential content and intellectual property (IP) assets from leakage - malicious or accidental - without impacting collaboration between all stakeholders.

Furthermore, products include ClassiDocs™, LandStar’s award-winning data classification and governance technology that supports CCPA, LGPD and GDPR compliance; and ClassiDocs™ for Blockchain, which provides an active implementation for the Ripple XRP, which protects blockchain transactions from inadvertent disclosure and data leaks.

Additionally, LandStar’s products include the WordPress GDPR Framework with more than 20,000 active users. It permits organizations of all sizes to comply with the GDPR and other privacy frameworks. Products also include The Virtual Data Protection Officer program, which offers a turnkey and outsourced DPO capability for smaller organizations; and, Data443™ Privacy Manager, which enables the full lifecycle of Data Privacy Access Requests, Remediation, Monitoring, as well as Reporting.

Yesterday, Data443 Risk Mitigation, Inc. (OTCPK: LDSRD, LDSRD), announced that it completed its planned reverse split of its common stock and corporate rebranding. It amended its corporate charter in the State of Nevada to become “Data443 Risk Mitigation, Inc.,” which was effective on October 16, 2019. The former name, LandStar, Inc., will no longer be used.

For the next 20 business days (starting October 29, 2019) the trading symbol will temporarily be LDSRD. Following this period, the Company will then commence trading under the new ticker symbol, “ATDS,” which the Company feels more appropriately reflects the activities of the business – ‘All Things Data Security™’.

LandStar, Inc. (LDSRD), closed Wednesday's trading session at $0.651, up 0.153846%, on 17,422 volume with 45 trades. The stock's 52-week low/high is $0.65/$0.88.

chart

Nocera, Inc. (NCRA)

OTC Markets, Stock Scores, Stock Pulse, Emerging Growth, Morningstar, GuruFocus, Stockopedia, PR Newswire, Nasdaq, Simply Wall St, Wallet Investor, TradingView, Last10k, Dividend.com. YCharts, Whale Wisdom, InvestorsHub, and Stockwatch reported earlier on Nocera, Inc. (NCRA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nocera, Inc. is a provider of design, build, and installation services of aquaculture (fish farm) equipment. It also provides technical assistance to the operators of the equipment. The Company operates chiefly through its Grand Smooth, Inc. subsidiary. Nocera lists on the OTC Markets. The Company is headquartered in Atlanta, Georgia.

Nocera’s first-generation RAS (Recirculating Aquaculture Systems), container system, was introduced as a new and very simple way for local fish farmers to breed fish in Xing Yi, a city of Guizhou, China. In 2018, the Company accomplished the development of its 2nd generation RAS, cylindrical tank system that generates greater than two times of fish harvest of container system yearly. Nocera has strategically partnered with CIMC to launch 4 new sites using its 2nd generation RAS in Guizhou.

Nocera’s Land-Based RAS can be utilized for saltwater and freshwater species. The RAS systems recycle water, and in the process help preserve the ecosystem through decreasing pollution from an over concentration of fish in natural waterways or bodies. The Company’s RAS tanks can produce up to 20,000-30,000 lbs. of fish per year.

Nocera’s plan is to expand its services outside of China, such as Taiwan, the United States, Japan, and Thailand, through building its land-based RAS demo sites and fish farms. These promote the environmental benefits of its land-based RAS and let the public participate in its fish farming business.

Yesterday, Nocera announced that it entered into a Project Contract for 400 Recirculating Aquaculture System (RAS) tanks in Kaili, Guizhou province, China with Dongguan CIMC Intelligent Technology Co., Ltd (DG CIMC). The anticipated value of the tanks to be produced and delivered is roughly $5.7 million US dollars based upon present foreign currency exchange rates.

Mr. Yin-Chieh "Jeff" Cheng, Chief Executive Officer, of Nocera stated, "We are very pleased with the contract agreement. This is a substantial movement in the right direction and continues our production and delivery of RAS tank systems to Chinese fish farms…In 2018, we produced and delivered 473 tank systems to our Chinese customers. We expect that the long term demand over the next several years in China to be more than 10,000 systems, and more than 16,000 systems worldwide."

Today, Nocera announced that it entered into a Regional Agency Cooperation (Marketing) Agreement with JC Development Co. Ltd. encompassing the Asian region. With this agreement, JC Development will act as Nocera's sales representative for the Asian region. JC Development (Taipei, Taiwan) is an equipment trading company with operations in greater China and Asia.

Nocera, Inc. (NCRA), closed Wednesday's trading session at $2.55, up 18.6047%, on 4,374 volume with 36 trades. The average volume for the last 3 months is 224 and the stock's 52-week low/high is $0.209999993/$4.3499999.

chart

Todos Medical Ltd. (TOMDF)

Stock Day Media, Stock News Now, GlobeNewswire, TalkMarkets, Morningstar, InvestorsHub, Investors Hangout, Otc.watch, Wallet Investor, OTC Markets, TradingView, Market Screener, Stockopedia, Proactive Investors, and Stockhouse reported beforehand on Todos Medical Ltd. (TOMDF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Todos Medical Ltd. concentrates on the development of blood tests for the early detection of cancer and neurodegenerative disorders, including Alzheimer's disease (AD). A clinical-stage in-vitro diagnostic company, it does so through Breakthrough Diagnostics, Inc., its joint venture (JV) with Amarantus Bioscience Holdings, Inc. Breakthrough Diagnostics is developing the Alzheimer’s blood diagnostic LymPro Test®. Todos Medical lists on the OTC Markets Group’s OTCQB. The Company is headquartered in Rehovot, Israel.

Todos Medical has developed two cancer screening tests based on TBIA (Todos Biochemical Infrared Analyses). This is a method for cancer screening utilizing peripheral blood analysis. The TBIA screening method is founded on the cancer’s influence on the immune system, which triggers biochemical changes in peripheral blood mononuclear cells and plasma. The proprietary and patented method incorporates biochemistry, physics, and signal processing.

Todos Medical’s TBIA platform represents a cost effective, scalable, and patient friendly screening method for cancer screening. The TBIA method is a proprietary method for the screening of solid tumours employing peripheral blood spectroscopy analysis. This process involves observing the immune system’s response to tumor presence instead of looking for the tumor cells themselves or specific markers. TBIA analyzes the whole biochemical signatures spectrum (including proteins, lipids, nucleic acids and carbohydrates) of effected immune cells from peripheral blood, using infrared spectroscopy.

The Company’s two cancer screening tests, TM-B1 and TM-B2, have received the CE mark. Todos Medical’s new cancer test will add a layer to currently available cancer screening and diagnostics. Its technology is a platform. Todos is investigating methods for using its platform on other types of cancers. At first, Todos is focused on breast and colon cancers.

Recently, Todos Medical and Orot+, the operational division of Orot-Luces, that executed a distribution agreement with Todos for the commercial distribution of Todos’ TM-B1 and TM-B2 blood screening tests for breast cancer, announced the enrollment of the first patient in the pre-commercial launch study of TM-B1 and TM-B2 in Europe. The expectation is that the pre-commercial launch study will last roughly 6 months.

Upon completion of the pre-commercial launch study, TM-B1 and TM-B2 are expected to be available for commercial sale in Romania by Orot. Orot is providing full funding for the pre-commercial launch study and also the commercial launch in accordance with the terms of the exclusive distribution agreement.

Todos Medical Ltd. (TOMDF), closed Wednesday's trading session at $0.10, even for the day, on 6,500 volume with 2 trades. The average volume for the last 3 months is 19,152 and the stock's 52-week low/high is $0.05/$0.340000003.

chart

Creative Medical Technology Holdings, Inc. (CELZ)

Live Trading News, MarketWatch, Emerging Growth, Stockhouse, Bio Quick News, Capital Cube, OTC Markets, InvestorsHub, Canadian Insider, and 4-Traders reported earlier on Creative Medical Technology Holdings, Inc. (CELZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Creative Medical Technology Holdings, Inc. (CMT) is a clinical stage stem cell company listed on the OTC Markets Group’s OTCQB. The Company’s focus is on Urology and Neurology using stem cell treatments. Since 2011, CMT and its affiliate company, Creative Medical Health, Inc., have concentrated on regenerative medical solutions for unmet Urological and Neurological needs.  The Company has a patent portfolio that encompasses all treatments.  CMT has its corporate office in Phoenix, Arizona.

The Company has formed CaverStem International LLC. This is a majority-owned subsidiary centered on commercializing stem cell therapy for erectile dysfunction to global physicians and their patients. CaverStem is offering the Caverstem™ technology to selected physicians in the United States that qualify according to CMT's criteria.

CMT has also established CerebroStem LLC. This majority-owned subsidiary focuses on developing stem cell therapies for brain injuries and neurodegenerative diseases. Its initial focus will be treating radiation induced brain damage.

Via its own research and collaborations with top academic institutions, CMT has acquired a pioneering stem cell (AmnioStem) and developed proprietary protocols. Moreover, the Company has built an extensive intellectual property (IP) portfolio, developed complete treatment offerings for erectile dysfunction (ED), and launched a 40-patient trial for ED at UCLA.  CMT is also making advances for treating stroke using its newly acquired amniotic fluid-based stem cell. 

AmnioStem is Amniotic fluid derived stem cell. The AmnioStem patent covers means to isolate, grow, and use amniotic fluid derived stem cells in a scalable and commercializable way. AmnioStem cells do not necessitate matching with the recipient, as one size fits all.

Recently, CMT  announced an update of its activities. Regarding CaverStem domestic activities, the Company is continuing marketing to physicians throughout the U.S. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and growing each month. CMT anticipates reaching financial self-sufficiency by revenues from sales this year.

Creative Medical Technology Holdings, Inc. (CELZ), closed Wednesday's trading session at $0.0005, up 25.00%, on 16,004,750 volume with 60 trades. The average volume for the last 3 months is 53,657,310 and the stock's 52-week low/high is $0.000399999/$0.020899999.

chart

Rego Payment Architectures, Inc. (RPMT)

Morningstar, Stockopedia, Simply Wall St, Corporate Information, Dividend Investor, Investing.com, Wallet Investor, Marketbeat, StockInvest.us, Barchart, 4-Traders, Investors Hangout, Investor Village, Penny Stock Hub, Stockrow, Market Screener, OTC Markets, YCharts, Stockhouse, Financial Content, Plunkett Research, Real Investment Advice, GuruFocus, TradingView, InvestorsHub, and MarketWatch reported previously on Rego Payment Architectures, Inc. (RPMT), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Rego Payment Architectures, Inc. formerly operated under the name Virtual Piggy, Inc. On March 16, 2017, the Company, creators of the only COPPA compliant technology aimed at providing payment capability for the under 18 market, announced its name change to reflect the progression of the Company into more wide-ranging payment-related markets. OTCQB-listed, Rego Payment Architectures is based in Cerritos, California.

Rego Payment Architectures, Inc. became an umbrella under which the Intellectual Property (IP) developed becomes available to many varied industries beyond the under 18 market. Rego’s core technology base is established on validated artificial intelligence (AI) techniques. It has extensive capability to adapt to a wide variety of payment markets and users. This core technology consists of ReTRO (Real Time Regulatory Oversight), established on advanced AI techniques, a system of reasoning engines, and a Contract Model (CM), which allows the creation of specific boundary conditions for its use.

Rego Payment Architectures also has its NOMad (Networks of Meaning ad-vantage). This is an advanced data mining application. It monitors people and the things they interact with. Additionally, the Company has its RSM (Rego Payment Architectures, Secure Financial Messaging) - the payment control system.

Rego’s flagship product is the COPPA compliant OINK payment platform. OINK is a tool that provides a secure mechanism for children to initiate purchases online that are parent controlled and monitored while also learning to manage their money. OINK (Online Instant Networking Keypad) is a technology that speeds up payments and makes making payments simple and streamlined.

Recently, Rego Payment Architectures announced a strategic partnership with Source Digital, Inc. The partnership opens a strong gateway to real-time, interactive "watch and shop" capabilities on any screen, in any environment, designed to totally protect the family e-commerce lifestyle by way of a secure and seamless buying experience.

Rego has partnered with Source™, a consumer experience platform designed for the video content creator to monetize their audience via real-time engagement. The two companies are working jointly to create a fully autonomous, integrated, family payment solution for this new frictionless economy. Rego Payment Architectures, in its new partnership and licensing agreement with Source™, will soon be ready to officially launch its family wallet. This wallet is COPPA compliant on Apple and Android devices.

Rego Payment Architectures, Inc. (RPMT), closed Wednesday's trading session at $0.19, up 18.75%, on 7,500 volume with 2 trades. The average volume for the last 3 months is 30,892 and the stock's 52-week low/high is $0.090999998/$0.280000001.

chart

Black Cactus Global, Inc. (BLGI)

StreetInsider, Insider Financial, The Street, 4-Traders, Morningstar, Stockopedia, Dividend Investor, PennyStockHub, Stockhouse, Simply Wall St, MarketNewsUpdates, Tip Ranks, Stockwolf, Barchart, InvestingNewsAlerts, Stock Press Daily, InvestorsHub, OTC Markets, and InvestorsHangout reported previously on Black Cactus Global, Inc. (BLGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Black Cactus Global, Inc. is a technology development business focusing on Blockchain, machine learning, cryptocurrency, and the Internet of Things (IoT). Its corporate mission is to pioneer the application of Blockchain and overlapping technologies to protect IP (Intellectual Property) and the security of data and financial transactions. The Company is developing Blockchain applications for FinTech, Healthcare, Media and Supply Chain employing smart contracts and machine learning. Black Cactus Global is based in Las Vegas, Nevada.

The Company’s strategic plan is to become the first totally integrated digital financial institution with Blockchain technology as its operating foundation. Black Cactus Global’s services include Blockchain Applications, Trading Exchange, KYC/AML Biometrics, Music Exchange, and Card Programs and Payment Systems.

In addition, its services include Crypto Currencies, Internet of Things (IoT), Smart Contracts, as well as FinTech & MedTech. Black Cactus Global specializes in worldwide development and consulting projects in its key development areas of FinTech, digital media, financial services, KYC, AML, cyber security, and healthcare.

Black Cactus Global announced in January of this year that it entered into an MOU (Memorandum of Understanding) with the majority shareholders in an Indian Technology firm to establish a subsidiary of the Company. With the MOU, Black Cactus Global will become the largest stakeholder of a global Technology company with offices in the ‘FinTech Valley’ Vizag Software Technology Park in Visakhapatnam, India, through which it will center on and advance the use of its innovative Blockchain based IP.

In May 2018, Black Cactus Global announced that it completed a share exchange agreement with the Blockchain development subsidiary, Black Cactus Global Technologies Pvt. Limited (BCG-TPL). The agreement calls for Black Cactus Global to own an initial 29 percent interest in BCG-TPL, which has already attained major milestones that will enable Black Cactus to scale-up development activities.

Regarding Healthcare, Black Cactus Global concentrates on creating opportunities for digital health economies via Blockchain with AI, IoT, and Machine Learning. Pertaining to Energy, the Company offers privatized network grid provision to isolate green energy from traditional energy sources and a chain code logic to manage energy distribution and estimation.

Black Cactus Global, Inc. (BLGI), closed Wednesday's trading session at $0.0077, up 20.6897%, on 333,699 volume with 10 trades. The average volume for the last 3 months is 201,491 and the stock's 52-week low/high is $0.000699999/$0.037999998.

chart

Tiger Reef, Inc. (TGRR)

Investors Hub and MarketWatch reported on Tiger Reef, Inc. (TGRR), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Tiger Reef, Inc. is a diversified producer of ultra premium rums under the Tiger Reef® brand. Also, the Company is a developer of casual dining restaurant properties in the Caribbean under the Mermaid Reef Ocean Grill & Lounge™ brand. The Company formerly went by the name Blue Water Bar & Grill, Inc. It changed its corporate name to Tiger Reef, Inc. in October 2016. 

The Company is a subsidiary of BWG Investments & Development, Ltd. Tiger Reef’s shares trade on the OTC Markets’ OTCQB. Tiger Reef is based in Cole Bay, the Netherlands Antilles.

  Tiger Reef has established a new wholly-owned operating subsidiary in St. Maarten, Dutch West Indies under the name Mermaid Reef, B.V.  Mermaid Reef will own and operate the initial Mermaid Reef Ocean Grill & Lounge™ in St. Maarten. 

In May 2017, Tiger Reef announced that its wholly-owned subsidiary, Tiger Reef Spirits, Ltd., entered into a Letter of Intent  (LOI)  with International Spirits & Beverage Group, Inc. (ISBG). ISBG is a Nevada based alcoholic beverage company. It specializes in the development, marketing,  and global sales of innovative wine and spirits brands.

ISBG will assist Tiger Reef with obtaining U.S. regulatory approval for the complete line of Tiger Reef® ultra premium rums. In addition, ISBG will become the U.S. importer of record for Tiger Reef’s complete line of rums.

The Mermaid Reef Ocean Grill & Lounge™ was being developed at Simpson Bay Resort & Marina on the island of St. Maarten, Dutch West Indies. Key elements of the Restaurant floor plan included the restaurant encompassing 2,466 sq. ft. of indoor and outdoor waterfront space.

In October of 2017, Tiger Reef issued its first statement and shareholder update since the Company’s St. Maarten headquarters experienced a direct hit from Hurricane Irma during the early morning hours on September 6, 2017. Tiger Reef’s office headquarters suffered catastrophic damage during the Hurricane Irma storm.

All of the Company’s office equipment, computers, paper files, and more were damaged beyond repair during the storm. However, electronic files were backed up offsite and were recovered. Tiger Reef was renovating a leased waterfront restaurant space in the Simpson Bay Resort & Marina in preparation of opening the first Mermaid Reef Ocean Grill & Lounge™ in time for the 2017 tourist season. In addition, Simpson Bay Resort & Marina and the Company’s restaurant location suffered massive damage and flooding.

Tiger Reef and Simpson Bay Resorts & Marina Management had numerous discussions since the storm concerning the future of the resort and restaurant. Based on the fact that the resort would be closed for a minimum of six months, but probably longer, and other uncertainties, Tiger Reef and Simpson Bay Resorts & Marina mutually agreed to terminate the lease agreement for the restaurant space. Tiger Reef will make a one-time write-off or its lost investment in this restaurant property.

Tiger Reef temporarily suspended all efforts related to the Mermaid Reef Ocean Grill & Lounge™ brand. The Company said this past October that it would re-evaluate its options for the brand in the coming months after it recovers from the losses incurred due to Hurricane Irma.

Tiger Reef, Inc. (TGRR), closed Wednesday's trading session at $0.0003, even for the day, on 2,903,000 volume with 5 trades. The average volume for the last 3 months is 23,377,253 and the stock's 52-week low/high is $0.0003/$0.006.

chart

Zoompass Holdings, Inc. (ZPAS)

MarketWatch and InvestorsHub reported on Zoompass Holdings, Inc. (ZPAS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Zoompass Holdings, Inc. is a top financial services technology enterprise headquartered in Toronto, Ontario. The Company is a financial platform provider. It has divisions in physical prepaid cards, financing enablement, as well as mobility products. Zoompass Holdings lists on the OTC Markets Group’s OTCQB.

In January of 2017, the Company received approval from FINRA (the Financial Industry Regulatory Authority, Inc.) to change its name from UVIC, Inc. to Zoompass Holdings, Inc. The Company's ticker was changed to ZPAS from UVVC.

In February of 2017, FINRA approved a 3.5 forward split for shareholders of record on September 7, 2016. Both actions were approved by the majority of shareholders on September 7, 2016.

In the card sector, the Company provides complete program management services for a wide assortment of open loop Visa® and MasterCard® prepaid and virtual card accounts. The Company enables businesses to provide their customers with a number of open loop card choices. These include gift cards, incentive cards, check replacement cards, as well as online virtual card accounts.

Zoompass can support clients’ program management needs, provide turnkey program management services, including program concept, card design, card submission and approval, client portal design and development, administration management, reporting and customer service support.

The Company also provides advanced mobile technology. This enables businesses to provide their customers with a white label mobile wallet solution, such as Zoompass, with the ability to manage their card balances, bill pay, transfer funds, and perform card to card money transfers in real time using their mobile devices.

The Zoompass Platform and the Prepaid Card Solution can be combined with the Company’s Mobile Money technology to transform a business. Zoompass works to guide small to midsize enterprises through payment needs situations, market and organizational assessments, and process requirements, to streamline existing capabilities, identify opportunities, and boost profitability.

Zoompass provides robust financial services virtually through one of the most advanced platforms available. It provides businesses and government tailored solutions to help digitize their financial transactions.

The Company’s platform drives banking independence, personal financial accountability, and new revenue opportunities for small and large businesses. Zoompass’ mobile device division helps carriers and mobile device manufacturers integrate the financial platform technology into their offerings.

Recently, Advanced Credit Technologies, Inc. (CyberloQ) announced it started the integration process with Program Manager, Zoompass and related Banking partners to launch Advanced Credit Technologies’ first Pre-Paid Card platform, the Kingdom Card.

The Kingdom Card combines “FRAUD” mitigation by way of the CyberloQ™ protocol, and “FINANCIAL LITERACY” via the TurnScor credit restoration platform. The Kingdom Card has the capacity to help millions of individuals with financial problems through TurnScor, while protecting their monies with CyberloQ™ fraud protection.

Zoompass Holdings, Inc. (ZPAS), closed Wednesday's trading session at $0.0965, up 60.8333%, on 132 volume with 1 trade. The average volume for the last 3 months is 11,352 and the stock's 52-week low/high is $0.05/$0.245000004.

chart

Innovative Designs, Inc. (IVDN)

Greenbackers, Pennybuster, and PennyStocks24 reported earlier on Innovative Designs, Inc. (IVDN), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Innovative Designs, Inc. manufactures Insultex® House Wrap, the Arctic Armor® Line, hunting apparel, swimwear, wind shirts, jackets, and the multi-function "All in One" under the "IDI Gear" label featuring Insultex®. All of its products contain Insultex®. The Company’s products deliver premier warmth and comfort with insulating, windproof, as well as waterproof protection. Insultex® is the lightest and thinnest thermal insulation. Established in 2002, Innovative Designs is based in Pittsburgh, Pennsylvania.

Since its establishment, Innovative Designs has centered its efforts on completing the development, design, and prototypes of its products, and obtaining retail stores or sales agents to offer and sell its products. The Company primarily sells its products via agencies, distributors, independent sales agents, retailers, and a Website in the United States and Canada.

Additionally, the Company has concentrated its efforts on developing its website to sell more of its products, and on establishing distribution channels for its House Wrap® product.

Arctic Armor™ by IDI Gear is a 100 percent waterproof and windproof breathable nylon shell with Insultex® Thermal Insulation. The Company offers the Arctic Armor™ Suit. Each Arctic Armor™ suit uses three layers of its exclusive thermal insulator Insultex®. Moreover, Innovative Designs offers the Arctic Armor™ Ice Fishing Suit. The Company can also supply national home builders with its Insultex® House Wrap.

An example of Innovative Designs’ clothing products is its “Arctic Armor Extreme Cold Base Layer Shirt”. This shirt is 68.5 percent Thermo Cool Polyester and 31.5 percent Bamboo Charcoal. It is highly breathable and the wicking yarn keeps one comfortable and dry. It is ion-treated to promote oxygen uptake. It is also UV stable, and anti-static. The shirt also has anti-microbial technology to control odor.

Insultex® is the newest thermal insulation on the market. The material can be used in outerwear, gloves, hats, pants, tents, sleeping bags, coolers, boots, swimsuits, blankets, comforters, and other items.

Insultex® incorporates countless micro air cells. These individual pockets trap air and do not allow it to escape. This is the key to keeping people warm. Insultex® directly reflects the body’s radiant heat back to the body. Insultex® is windproof, waterproof, and buoyant.

Recently, Innovative Designs announced that it entered into a sales agreement with New Thinking Fashion USA, Inc. New Thinking Fashion USA specializes in the sale of finished fabrics to a broad assortment of apparel manufacturers. It will present Insultex™ to several of their present clients. New Thinking Fashion USA is a multilevel selling organization in the heart of the garment district on West 38th Street, New York, New York.

Innovative Designs also announced that, in an attempt to grow its worldwide business, entered into a 2 year agreement with Epoch Consultants LLC, who has been granted exclusive rights in India. Epoch Consultants will be conducting marketing of Insultex™ to apparel manufacturers and the Indian military.

Innovative Designs, Inc. (IVDN), closed Wednesday's trading session at $0.345, up 33.7209%, on 31,129 volume with 15 trades. The average volume for the last 3 months is 3,956 and the stock's 52-week low/high is $0.0271/$0.50.

chart

Agritek Holdings, Inc. (AGTK)

CFN Media Group, Promotion Stock Secrets, PennyPro, SmallCapVoice, and Cannabis Financial Network News reported on Agritek Holdings, Inc. (AGTK), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Formed in 2010, Agritek Holdings, Inc. is a fully integrated, active cannabis real estate investor and branding consultant in the legal cannabis sector. The Company provides innovative technology and agricultural solutions for the medicinal and recreational cannabis industry. Currently, Agritek owns property in Colorado approved for cultivation, and manufacturing capabilities through California partnerships. It also owns a number of Hemp and cannabis brands for distribution including "Hemp Pops" and "California Premiums". Agritek Holdings is headquartered in Miami, Florida. The Company has a satellite office in San Juan, Puerto Rico.

Agritek does not directly grow, harvest, or distribute or sell cannabis or any substances that violate or contravene United States law or the Controlled Substances Act. It does not intend to do so in the future. The Company’s solution is an integrated platform designed for commercialization in three high-value segments of the global cannabis market – Real Estate, AGTK Brands/IP, and Infrastructure.

Agritek’s Colorado property is 80-Acres approved for cannabis cultivation or manufacturing facility in Pueblo, Colorado. Its Puerto Rico property is a 25,000-sq. ft. licensed cannabis cultivation and manufacturing facility. Agritek’s Canada property is a cannabis friendly "Bud & Breakfast" concept. It is one 1-hour from Quebec City. It is on 15-acres that includes nine guest rooms plus a separate detached grow facility.

Agritek’s brands are a premium positioned set of consumer brands for medical wellness and recreational use. Agritek owns a number of hemp and cannabis brands for distribution. These include MD Vapes, MicroDose Strips, and the above-mentioned "Hemp Pops" and "California Premiums."

Agritek Holdings announced this past April that it completed, and fully executed, a five-year operational and exclusive licensing agreement with a 25,000-sq. ft. and one of the largest approved cultivation facilities in San Juan, Puerto Rico. The Company will be the exclusive funding source, and supervise all infrastructure buildout, equipment lease/finance, security systems and personnel and provide access of experienced Colorado and California cultivation crews to ensure the facility meets all standard operating procedures as set forth by the Department of Health of Puerto Rico.

With the five-year operational contract and licensing agreement, Agritek will receive revenue in the form of property rent, licensing fees on all vaporizer and edible brands, equipment and lighting rental and financing fees along with equity interest in the property.

Also, in May, Agritek Holdings announced that it executed a land purchase agreement to purchase a "420 Style" resort and estate property about one hour outside of Quebec City, Quebec. This 15-acre estate comprises nine innovative guest suites and horse stables. It is within walking distance to a public golf course that the Company will have ownership in for guests staying at the resort. A separate structure will serve as a small grow facility run by patient employees and caretakers on the property that may be toured by guests of the facility.

Recently, Agritek Holdings announced that Phase One of construction is commencing this month at the 1919 Clinic's 25,000 square foot cultivation and manufacturing facility located in San Juan, Puerto Rico. Agritek will provide funding for the build out of the operation, extraction and all equipment, and cultivation experts under the Agritek team via its executed five-year Operations and Licensing Agreement with 1919 Clinic.

Agritek Holdings recently announced its initial orders from its' state licensed manufacturer for its brand "MicroDose" Oral Strips or "MD Strips" for the medicinal market of California. First orders and samples are being sent to dispensaries and local delivery services in San Diego and Orange County this month. Agritek will provide the licensing and packaging to produce the exclusive line of 10 mg and 50 mg oral strips as a medicinal alternative for patients.

Agritek Holdings, Inc. (AGTK), closed Wednesday's trading session at $0.17, up 4.6154%, on 66,197 volume with 35 trades. The average volume for the last 3 months is 23,295 and the stock's 52-week low/high is $0.150000005/$1.94000005.

chart

The QualityStocks Company Corner

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)

The QualityStocks Daily Newsletter would like to spotlight Standard Lithium Ltd. (OTC: STLHF).

Lithium-focused exploration company Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) this morning announced the company’s entrance into a C$5,000,000 loan and guarantee agreement with LANXESS Corporation (the “lender”). The loan has been fully advanced to the company as US$3,750,000, based on an agreed exchange rate, and will be utilized in the ongoing development of a demonstration plant in southern Arkansas. To view the full press release, visit http://nnw.fm/7zS7b.

Standard Lithium Ltd. (OTC: STLHF) is focused on unlocking the value of existing large-scale U.S.-based lithium brine resources that can quickly be brought into production. The Company believes new lithium production can rapidly be brought on stream by minimizing project risks at selection stage; resource, political & geographic, and regulatory & permitting; and by leveraging advances in lithium extraction technologies and processes.

The Company’s flagship project is in southern Arkansas. The more than 180,000-acre “Smackover Project” is in the most prolific and productive brine processing region in North America. Agreements with large commercial brine operators in the region will allow Standard Lithium to utilize the extensive existing infrastructure, including brine supply and disposal pipelines, water, power and a trained workforce to fast-track project development timelines.

“Arkansas produces about 9.4 billion gallons of brine per year, according to 2010-2016 average statistics reported by the Arkansas Oil & Gas Commission.”

Standard Lithium signed a binding MoU with global specialty chemicals company LANXESS Corporation and its U.S. affiliate Great Lakes Chemical Corporation with the purpose of demonstrating the commercial viability of extraction of lithium from brine (“tail brine”) that is produced as part of LANXESS’ bromine extraction business at its three Southern Arkansas facilities.

LANXESS’ land operations in Southern Arkansas encompass more than 150,000 acres, 10,000 brine leases and surface agreements and 250 miles of pipelines. LANXESS extracts the brine from its wells located throughout the area, and the brine is transported to the three Arkansas plants through a network of pipelines. The three bromine extraction plants currently employ approximately 500 people and process and reinject several hundred thousand barrels of brine per day.

Standard Lithium has developed a breakthrough rapid lithium extraction process that reduces the recovery time of extracting lithium from brine to as little as several hours vs. the current industry method that takes years. The process is also much more environmentally friendly with a significantly smaller footprint than the conventional processes. The company has a signed agreement to locate a demonstration scale lithium extraction plant inside one of LANXESS’ chemical plants in Southern Arkansas.

The Company has also signed an option agreement with NYSE-listed Tetra Technologies for the lithium rights for exploration, extraction, and possible commercial development on approximately 30,000 acres of brine leases in Southern Arkansas. The largest available land package.

Recent laboratory results of four brine samples recovered from two existing wells in Standard Lithium’s project area showed lithium concentrations ranging between 347-461 mg/L lithium, with an average of 450 mg/L lithium in one of the wells and 350 mg/L in the other. Geological modeling of the project area is complete, and a maiden resource report is on the horizon.

Market Opportunity

World demand for lithium continues to surge. The global lithium compounds market is projected to reach U.S. $5.87 billion by 2020 at a compound annual growth rate of 13.22% between 2015 and 2020. Lithium-ion batteries are the fastest growing segment of the market.

Leadership

Standard Lithium’s commitment to being a premier, innovation-driven company focused on developing and commercializing new modern processes for lithium extraction is bolstered by the leading experts that comprise the company’s Scientific Advisory Council. Each member was selected because of their experience and expertise in areas that are central to and/or complement Standard Lithium’s current development plans. Standard Lithium recently welcomed to the Council world-renowned chemist Dr. Barry Sharpless, the recipient of the 2001 Nobel Prize in Chemistry for his work on chirally catalyzed oxidation reactions.

Standard Lithium is led by a team of professionals with proven strong technical and project development skills. CEO Robert Mintak has a global network of industry contacts and is a pioneer in the rapidly evolving lithium space. COO and President Dr. Andy Robinson is an experienced geoscientist with 20+ years of experience and a PhD in Geochemistry from the University of Bristol, UK. Dr. Robinson has worked on a wide range of projects in the resource, power and energy sectors in Europe, Africa, and North and South America.

The company recently appointed Robert Cross as non-executive chairman. Cross is an engineer with 25 years of experience as a financier and company builder in the mining and oil and gas sectors. He co-founded and serves as chairman of B2Gold, a top-performing growing gold producer which is expected to achieve nearly 1 million ounces of low-cost gold production in 2018. He was also co-founder and chairman of Bankers Petroleum Ltd.; co-founder and chairman of Petrodorado Energy Ltd.; and until October 2007 was the non-executive chairman of Northern Orion Resources Inc. He also was previously the chairman and CEO of Yorkton Securities Inc., and a partner in investment banking with Gordon Capital Corp. in Toronto. Cross has an engineering degree from the University of Waterloo (1982) and received an MBA from Harvard in 1987.

Following a multi-million-dollar financing in Q1 2018, Standard Lithium is well-positioned to meet its upcoming milestones including two maiden resource reports and the launch of its breakthrough rapid lithium extraction technology.

Standard Lithium Ltd. (OTC: STLHF), closed Wednesday's trading session at $0.5711, up 11.543%, on 74,073 volume with 35 trades. The average volume for the last 3 months is 25,416 and the stock's 52-week low/high is $0.483999997/$1.12.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1)on Tuesday announced that it has parted ways with its Chief Advocacy Officer John Fowler. In the update, Supreme Cannabis thanked Fowler for his years of dedication and strong contribution to the company, as well as his passion for the cannabis plant. To view the full press release, visit http://cnw.fm/l9LA5.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Wednesday's trading session at $0.55, up 7.5269%, on 617,512 volume with 386 trades. The average volume for the last 3 months is 506,923 and the stock's 52-week low/high is $0.503899991/$1.7888.

Recent News

chart

HTC Extraction Systems (TSX.V: HTC)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC).

HTC Extraction Systems (TSX.V: HTC), a hemp-biomass processing entity, today announced that it has closed its bought deal private placement resulting in gross proceeds of $10 million. In addition, the company reported the completion of its 19,000-square-foot facility that will house quality assurance testing and product development laboratories and extraction and formulation processing. To view the full press release, visit http://cnw.fm/l9z8E. Also today, the company was featured in a publication from CBDWire, examining how, after successfully raising $10 million in a private placement financing of 25 million units of the company, HTC Extraction Systems (TSX.V: HTC) is poised to expand its role in the cannabidiol (CBD) extraction market. HTC plans to use the funds for purchase of extraction, purification and refining equipment, and for general working capital purposes, the company stated in a news release (http://cnw.fm/YBa1g). Furthermore, CBDWire highlighted the company in an article discussing how cannabidiol (CBD) has been making waves in the medical, sports, health, and wellness community. Its pain-relieving properties have especially captivated people, and there has been a push to legalize its use for pain-relief in the sporting world. A revelation from a retired football player might just give this campaign a push in the right direction.

HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (TSX.V: HTC), closed Wednesday's trading session at $0.38, up 8.5714%, on 164,000 volume with 17 trades. The average volume for the last 3 months is 113,215 and the stock's 52-week low/high is $0.079999998/$1.24.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (OTCQB: CIIX), an established financial news and investment portal and a leading industrial hemp retailer for the Chinese-speaking community, today announced that its subsidiary CBD Biotech, Inc. will attend the "2019 China Industrial Cannabis Investment Seminar" in Shanghai, China on October 31, 2019. To view the full press release, visit http://cnw.fm/Sr2wS.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Wednesday's trading session at $0.22, up 10.00%, on 14,892 volume with 8 trades. The average volume for the last 3 months is 44,149 and the stock's 52-week low/high is $0.180000007/$0.689999997.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

VPR Brands LP (OTCQB: VPRB), a multi-vertical tiered technology holding company in the cannabis space including vaping, joins other hemp industry players in their anticipation of the United States Department of Agriculture’s (USDA) release of an interim final rule for its Hemp Program. This announcement is timed in advance of the 2020 planting season and should guide producers with a framework for their activities (http://cnw.fm/C1wQG). Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Possession and cultivation of marijuana for personal use is being considered for decriminalization by Finland’s government after marijuana advocates collected the 50,000-plus petition signatures required to prompt the parliament to review the measure.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit www.goldlinehemp.com for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed Wednesday's trading session at $0.04356, up 14.6316%, on 70,097 volume with 13 trades. The average volume for the last 3 months is 132,460 and the stock's 52-week low/high is $0.033799998/$0.119999997.

Recent News

chart

Neutra Corp. (OTCQB: NTRR)

The QualityStocks Daily Newsletter would like to spotlight Neutra Corp. (NTRR).

Early-stage research and development company Neutra Corp. (OTC: NTRR) executed a Letter of Intent (LOI) that could lead to the joint development of a vast selection of additional hemp-based medicinal products on the booming CBD market, according to a company press release (http://cnw.fm/hUH7u).

Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.

Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.

Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.

Acquisitions

  • VIVIS – Neutra continues to expand its market presence in the rapidly growing hemp-derived CBD market and recently acquired VIVIS, an emerging retail brand of hemp-based health and nutritional products. VIVIS’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With VIVIS as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
  • J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.

Partners

  • Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
  • ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.

Leadership

Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.

Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.

Neutra Corp. (OTCQB: NTRR), closed Wednesday's trading session at $0.0008, up 33.3333%, on 6,190,166 volume with 227 trades. The average volume for the last 3 months is 27,949,799 and the stock's 52-week low/high is $0.0006/$0.069799996.

Recent News

chart

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was featured today in a publication from HempWireNews, examining how it is the middle of the hemp harvest season, and farmers from Warren County, among them Andy Huston, the founder of American Hemp Research, are just beginning the harvesting process. He is one of the first farmers to grow hemp legally in Illinois and he shared what the journey has been like.

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Wednesday's trading session at $3.35, off by 1.1799%, on 1,636,824 volume with 5,678 trades. The average volume for the last 3 months is 1,321,975 and the stock's 52-week low/high is $2.71000003/$8.43999958.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) was featured today in the 420 with CNW by CannabisNewsWire. Possession and cultivation of marijuana for personal use is being considered for decriminalization by Finland’s government after marijuana advocates collected the 50,000-plus petition signatures required to prompt the parliament to review the measure.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Wednesday's trading session at $1.75, off by 2.2892%, on 25,648 volume with 63 trades. The average volume for the last 3 months is 38,390 and the stock's 52-week low/high is $1.75/$6.00810003.

Recent News

chart

GP Solutions (OTC: GWPD)

The QualityStocks Daily Newsletter would like to spotlight GP Solutions (GWPD).

GP Solutions (OTC: GWPD), the developer of proprietary, automated micro-farms called GrowPods, on Tuesday announced the launch of Prolific, a unique, proprietary soilless growth medium and nutrient line that is free of human and sewage waste. To view the full press release, visit http://cnw.fm/1Swkj.

GP Solutions (OTC: GWPD) is developing scalable farming systems for soil-less indoor organic farming. The company’s GrowPods are automated micro-farms that use hydroponic technology and unique soil systems to cultivate the highest-quality specialty leaf crops. The system is designed and engineered for ease of use, allowing users to farm year-round in any location of the world, supporting the company’s mission to provide customers with the ability to cultivate their own organic “superfoods.”

GrowPod Design & Function

GrowPod is a modular, stackable and mobile vertical growing environment specifically engineered to maximize yield and automation. GrowPods are available as a vertical pod, stacker pod or custom-built pod.

The Stacker Pod is a certified organic soil system that offers growers multiple levels of planting in order to maximize space and produce options with different fruits and vegetables. The Vertical Pod utilizes a vertical hydroponic system. It is affordable, scalable, efficient, automated and sustainable. The output provides customers with fresh and clean produce year-round in any climate. The Custom Pod is built to suit the farmer’s specific crop and grow goals.

Each 320-square-foot GrowPod container will have an annual production capability of up to four times that of outdoor growing methods, dramatically increasing profitability to the grower. The controlled environment of the GrowPod ensures efficient power and water usage in growing a wide range of horticultural and agricultural products in all environments and climates.

Thanks to a combination of hydroponic and certified organic soil systems, crop yields are higher, faster, and more consistent that conventional means. Customers can enjoy an average of eight higher yield crop cycles anywhere in the world.

GrowPod Features:

  • Modular, stackable and mobile
  • Fully insulated, food-grade shipping container
  • Engineered for automation
  • Efficient LED lighting
  • Hydroponic or soil-based platforms
  • Proprietary air and water filtration
  • Climate-controlled
  • Remote monitoring

GP Solutions also offers many services to its customers, including:

  • Shipment and installation service of its shipping container farms
  • On-site training
  • Provision of custom planting and harvesting schedule
  • Provision of growing supplies, seeds, nutrients, packaging, branding and repair materials
  • On-site visits, on-call and scheduled maintenance, and re-supply
  • Remote monitoring and automated control of environmental nutrients, environmental growth factors (PH, temperature, light) and circulation
  • Technical assistance
  • Consulting and custom facility systems design

Competitive Advantage

GrowPods allow cultivation to take place year-round, which maximizes ROI. The systems are sealed from outside pathogens, contaminants, pesticides, and the result is clean and robust crop production.

GP Solutions also has a line of remarkable new proprietary soil mixtures and nutrient lines which contain no animal products. These products are vital, as many other soils and additives can contain harmful pathogens and contaminants that can cause crops to become tainted or fail rigorous testing.

Global Solution

GP Solutions has partnered with the world’s leading food nonprofit companies, including Feeding America, Seeds of Hope, Habitat for Humanity, Meals on Wheels America, L.A. Kitchen, and Farm Bread, to help insecure communities take control of their own food dependence using container farms.

GP Solutions (GWPD), closed Wednesday's trading session at $0.90, off by 8.1633%, on 3,103 volume with 6 trades. The average volume for the last 3 months is 7,092 and the stock's 52-week low/high is $1.03999996/$21.00.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) was featured today in a publication from HempWireNews, examining how The Industrial Hemp Act, which legalized the growth of hemp in Illinois, was signed back in August 2018 by the former Illinois Governor, Bruce Rauner. When the Farm Bill which legalized industrial hemp production was passed in December 2018 by Congress, Illinois can now export the extracted CBD oil to other states. Also today, the company was featured in a publication from TheNewsWire, examining how LXRP is arranging a non-brokered private placement for gross proceeds of approximately US$1 million (the "Financing").

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hmep-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Wednesday's trading session at $0.5776, off by 10.9199%, on 275,375 volume with 159 trades. The average volume for the last 3 months is 86,027 and the stock's 52-week low/high is $0.399800002/$1.70000004.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (ETST) was featured today in a publication from CBDWire, examining how, last year, Congress passed the Farm Bill, legislation that legalized the cultivation and sale of industrial hemp, and by extension, the hemp extract CBD. It is the primary non-psychoactive agent in cannabis, and it has come to be known as a sort of wonder drug. Apart from managing chronic pain, it can help reduce anxiety, it has anti-aging properties and is useful in controlling seizures in children with epilepsy, among a host of diseases.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed Wednesday's trading session at $0.318, off by 9.1429%, on 23,810 volume with 14 trades. The average volume for the last 3 months is 41,392 and the stock's 52-week low/high is $0.280000001/$1.07000005.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) announced on October 18, 2019, the final closing of equity financing initiated one month prior. According to a news release, the company generated gross proceeds of $500,000 through the issuance of 2,777,777 units sold at $0.18 each (http://nnw.fm/8XlSF). Funds generated through the equity financing will be put towards the company’s innovative clean oil extraction technology.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PQEFF), closed Wednesday's trading session at $0.165, off by 0.662252%, on 70,521 volume with 27 trades. The average volume for the last 3 months is 240,073 and the stock's 52-week low/high is $0.112099997/$0.819999992.

Recent News

chart

LiveWire Ergogenics Inc. (OTC: LVVV)

The QualityStocks Daily Newsletter would like to spotlight LiveWire Ergogenics Inc. (LVVV).

LiveWire Ergogenics (OTC: LVVV), a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry, today announced the broadcast of its audio interview with NetworkNewsAudio (“NNA”), a NetworkNewsWire (“NNW”) solution. To listen to the interview, visit http://cnw.fm/Wffv2. To view the full press release, visit http://cnw.fm/C1s8P.

LiveWire Ergogenics Inc. (OTC: LVVV) is a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry. The company recognizes significant potential in the multibillion-dollar cannabis industry and operates at the forefront for acquisition and management of licensed cannabis real estate locations and the research, development and commercialization of high-end products for distribution throughout California.

During the past two years, LiveWire has diligently researched, secured, designed and set up several fully compliant and permitted cannabis operations in locations in California, including a state-wide distribution license from the Bureau of Cannabis Control. The company is focused on acquiring compliant real estate properties for cannabis operations and entering into operation agreements and strategic alliances to build teams of carefully selected and vetted operators, horticulturists, extractors, distributors and establish research partnerships. Its current portfolio of cannabis operations consists of the following properties:

PODs and Distribution in Coachella, California

For the past year, LiveWire has operated high-tech, state-of-the-art production structures, or “PODs” for its cannabis nursery business. Coachella is also home to the company’s statewide distribution headquarters. Both entities operate under LiveWire’s majority owned subsidiary, GHC Ventures. The company is currently in the process to strategically centralize all operations at its recently acquired Paso Robles facility, Estrella Ranch.

Estrella Ranch in Paso Robles, California

Through its subsidiary, Estrella Ranch Partners LLC, LiveWire acquired a 265-acre historic ranch property in Paso Robles, Calif. Estrella Ranch has a longstanding history, once owned by George R. Hearst, the eldest grandson of the late William Randolph Hearst, developer of Hearst Communications, and is considered among the finest ranches in California and the gem of the California Central Coast. LiveWire is transforming this property into the world’s first “Estate-Grown Weedery” with plans to develop it into a vertically integrated, high-end cannabis facility and wellness retreat in California. The stunning property, located in the heart of the world renown California wine country, currently houses three spacious residences, storage areas, and elaborate equestrian facilities with four barns and numerous stables. LiveWire is designing a truly unique property that features indoor and outdoor cannabis operations, including large outdoor and indoor cannabis production. Long-range plans include adding teaching and luxury recreational facilities focused on providing a comprehensive and unique cannabis-related retreat experience.

 

The Paso Robles Nursery

LiveWire has begun the build-out and will soon begin production in its 22,000-square-foot secure indoor cannabis nursery facility in Paso Robles, Calif. The project includes the conversion of two existing buildings with sufficient power capacity and abundant water supply. Floor plans include more than 10,000 square feet of canopy devoted to “mother” plants and separate clone storage; additional space has been identified for flowering plants. Within the two buildings, the nursery also contains research and development areas, rooms for cannabis waste and storage, record keeping and staging space, security offices, a conference room and additional designated locations required for permit approval and compliance.

LiveWire has spent significant resources to research and maneuver a complex legal environment and confirm the economic and environmental feasibility of potential LiveWire cannabis operations in different locations throughout the state of California. All LiveWire operations comply with California state law and local ordinances. To fully capitalize on these highly valuable assets, LiveWire is seeking funding to accelerate the development of its business plan.

GHC Ventures Subsidiary

GHC Ventures, LiveWire’s Coachella-based distribution division, employs a consumer-driven market approach that provides retailers access to a wide range of new high-end cannabis products, all serviced through the licensed and reliable GHC supply chain and distribution network.

GHC Ventures’ distribution network is available exclusively to licensed manufacturers that pass LiveWire’s stringent legal and environmental qualification process. This enables LiveWire to provide a large and solidly structured legal distribution network for all qualifying third-party operators in California. LiveWire is actively seeking to work with licensed operators who are enthusiastic and qualified to ensure the delivery of high-caliber and legal cannabis products for the fast-growing California medical and recreational cannabis markets.

Research Partnerships

LiveWire has established two independent research teams with world-renowned experts in their respective fields to pursue application of cannabis derivatives to specific targeted medical ailments. The company is also establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for both human and veterinarian applications. Possible applications may include dosing verification of zero-pesticide products for quality brands via its 7X Pure Cannabis Dosing and Verification System.

LiveWire has also engaged a highly qualified research team and advisory board to explore the opportunities in the unexplored yet highly valued equine space. The company has entered into consulting and/or advisory board agreements with high-caliber individuals from the medical and international-performance equine sector and is currently exploring strategic relationships with the veterinary departments of leading local and domestic universities and medical facilities.

7X Pure™ Dosing and Verification System

LiveWire Ergogenics is developing its “7X Pure Compliance and Dosage Verification System” intended to provide third-party verification of cannabis material origin, potency, purity, dosage and labeling, securing each product with a digital identity and clearly identifiable chain of custody.

The 7X Pure system will be completely secure, transparent and verifiable, protecting the confidentiality of growers’ and manufacturers’ intellectual property while providing retailers, consumers, government officials and others verification that the growers’ and manufacturers’ claims are true.

The system is designed as a parallel service to the seed-to-sale data provided by marijuana tracking software, will help growers and manufacturers meet increasing compliance requirements related to logistics, quality and transparency. It will also provide a high level of assurance to everyone from end users to municipalities.

Acquisitions & Operations

To maximize the utilization of its fully compliant locations and the licenses granted throughout California, LiveWire has begun and continues to pursue acquisitions of and/or strategic alliances with qualified cannabis companies and consultants. LiveWire will apply a strict regimen to the acquisition of operators, carefully utilizing its experience and legal standing in the California cannabis market for the selection of qualified operators.

Market Opportunity

Legal marijuana is the fastest-growing industry in the United States. Twenty-nine states have already legalized medical marijuana, eight states have approved it for recreational use, and more are following suit. Once the trend toward legalization expands to all 50 states, marijuana could become larger than the organic food industry, according to a new report obtained by The Huffington Post.

The U.S. marijuana industry is forecast to generate annual revenues ranging from $17 billion to $35 billion by 2021. The combined legal medical and recreational market has grown by roughly 30 percent, reaching $6 billion during 2017, according to The Marijuana Business Factbook. The same study projects the market will increase 300 percent to top $17 billion by 2021. During 2017 recreational sales grew by 80 percent, reaching $1.8 billion, not yet accounting for sales of the biggest revenue producer, California, which will only commence with recreational sales in 2018.

Business Model

LiveWire’s diligent approach to the cannabis sector is based on extensive environmental and legal research to predetermine the feasibility of the locations it selects for operations. The company pursues a carefully selected approach of acquiring, licensing and managing self-contained and permitted real estate properties for the development and distribution of its products and leasing to third party operators. LiveWire avoids the complications and high start-up cost of the typical large “growing” operations, instead focusing on becoming the market leader in research, cloning and verification, producing and distributing high quality brands.

Management Team

LiveWire’s team of experienced corporate managers and innovators are leading the company’s plans to capture increasing market share from different and often underserved market sectors in the cannabis industry. LiveWire intends to utilize its team’s experience to accelerate the development and/or acquisition of new properties, product offerings, and companies.

Bill Hodson, CEO & Chairman of the Board
Bill Hodson is responsible for the strategic direction of the firm’s development, branding, sales and marketing strategies. In addition to being responsible for the operation of the company, he leads the development and manages implementation of the company’s innovative product strategy. Previously the executive vice president of LiveWire Sports Group, Hodson was responsible for overseeing all LiveWire’s operations, including the launch of several sports publications and one of the country’s largest sports consumer expos.

As early as five years ago, Hodson recognized the potential of CBD and became an early adopter of CBD as a health and wellness supplement by including hemp-derived cannabidiol in a starburst size edible product. His experience includes not only product development, marketing and sales, but most significantly constant city and county advocacy, guiding the company through four license processes, identifying and spearheading real estate acquisitions, and to assemble operations teams comprised of nursery horticulturists, cultivators and distribution personnel. His vision for the industry is complimented with his out-of-the-box thinking and anticipation of positioning for the future.

Kyle McKay, Horticulturist
Kyle McKay is responsible for managing LiveWire’s controlled cultivation environment, developing new-age genetics to produce consistent and high-quality products for medical patients, and applying his expertise in integrated pest management with Omri-certified fungicides and pesticides. McKay oversees the company’s clone development and supervises both cultivation facilities in Coachella and Paso Robles. He also assists with location research and selection; cultivation center planning; operations set-up; and maximizing the growth potential of cannabis edibles, concentrates and oil production. McKay’s expertise in plant genetics and modern horticulture technology makes him extremely qualified to guide LiveWire’s efforts. During his 12-plus years in the cannabis horticulture field, he has grown more than 230 stable genetics, managed over 27 cultivation centers and grown the specific strains required to meet the needs of up to 45,000 medical cannabis patients at one time.

Advisory Board

Jeff Halloran, Investment Banker
Jeff Halloran is an accomplished senior-management executive with more than 35 years of experience. He has founded and held top positions in large financial and technology firms and has an outstanding record of achievement managing multimillion and billion-dollar programs. Halloran will use his standing in the Canadian markets to provide LiveWire with research and advice for potential acquisitions and strategic alliance targets in the burgeoning Canadian cannabis markets. Halloran has spent most of his career in leading management and consulting positions gathering extensive knowledge in strategic business analysis and information management theories. He served as managing director of Avalon Capital and Halloran Investment, as well as chairman and/or CEO of several companies owned by MT Dynamics. As a consulting manager he was recruited by Oracle Corporation to establish the multibillion-dollar organization’s consulting practice in Canada, eventually earning a place on the design team for Oracle Financials and its CASE Tool and Methodology. Halloran also heads up the executive committee for the Willow Breast Cancer Support Organization.

Michael Corrigan, Attorney at Law
Michael Corrigan is a legal professional at the Law Offices of Michael L. Corrigan, practicing in San Diego, Calif. His practice emphasizes general and SEC representation of emerging high-technology and other operating companies. He has been counsel to private and public companies in a broad range of industries, including computer hardware and software, telecommunications, multimedia and cannabis.

Matthew Geriak, Clinical Pharmacist and Investigational Research Pharmacist
Matthew Geriak is a specialized pharmacist and has a system-wide position on the Investigational Review Board for Sharp Healthcare, which owns five hospitals and various clinics throughout San Diego County. Sharp conducts drug research spanning from phase 1 to 4 human research clinical trials focusing on the fields of oncology, renal and heart transplantations, septic shock treatment, infectious diseases and anticoagulation. Geriak is the primary investigator for retrospective cohorts in the field of infectious diseases.

Jimmy Connors, Sports Industry Adviser
Jimmy Connors is a legendary No. 1 ranked tennis player and is considered among the greatest in the history of the sport. Today, Connors still holds three prominent Open Era Men’s singles records: 109 titles, 1,535 matches played, and 1,256 matches won. His titles include eight?majors, five U.S. Opens, two Wimbledons, one Australian Open, three year-end championships and 17?Grand Prix Super Series. Connors brings a wealth of knowledge in the sports and wellness industries that will be especially important as LiveWire expands into its next phase of development with its topical products. His decade-long exposure in the global sports world as one of the most recognized personalities adds a high level of exposure and supports LiveWire’s efforts to set itself apart in a fast-growing and still turbulent and disruptive industry.

LiveWire Ergogenics Inc. (OTC: LVVV), closed Wednesday's trading session at $0.0064, off by 7.2464%, on 942,876 volume with 27 trades. The average volume for the last 3 months is 939,535 and the stock's 52-week low/high is $0.004199999/$0.07.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

When shopping on Amazon, it seems like the multinational technology company knows its customers intimately. Every product filtered into a search query response seems carefully curated to match each customer. This ability to leverage big data has pushed Amazon to the peak of success, and it now accounts for approximately 50 percent of all purchases made online (http://nnw.fm/9p3Le). From the health care field Predictive Oncology Inc. (NASDAQ: POAI) has been garnering industry attention as a hidden gem in the field of precision medicine for its innovative use of data and algorithms.

Predictive Oncology (POAI) is a data and artificial intelligence-driven discovery services company that provides predictive models of tumor drug response to improve patient outcome. Predictive Oncology harnesses the power of artificial intelligence, collaborating with the pharmaceutical, diagnostic and biotech industries to develop highly customizable assessment methods for patients, which can lead to much more effective treatments.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable development of patient specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Predictive Oncology (POAI), closed Wednesday's trading session at $3.905, off by 2.6185%, on 23,632 volume with 232 trades. The average volume for the last 3 months is 7,343 and the stock's 52-week low/high is $3.31999993/$8.50.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.